Reproductive Health Training Center of the Republic of Moldova
Quick facts
Marketed products
- Medical abortion · Reproductive Health / Obstetrics
Medical abortion uses a combination of mifepristone (a progesterone receptor antagonist) and misoprostol (a prostaglandin analog) to terminate early pregnancy by blocking progesterone signaling and inducing uterine contractions.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Reproductive Health Training Center of the Republic of Moldova portfolio CI brief
- Reproductive Health Training Center of the Republic of Moldova pipeline updates RSS
Frequently asked questions about Reproductive Health Training Center of the Republic of Moldova
What are Reproductive Health Training Center of the Republic of Moldova's marketed drugs?
Top marketed products include Medical abortion.
Related
- Medical abortion · Reproductive Health / Obstetrics
- Sector hub: All tracked pharma companies